サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：長時間作用型モノクローナル抗体の世界市場規模：供給源タイプ別、適応症別、エンドユーザー別、地域別の予測（2022年～2028年）
市場調査レポート
商品コード
1071682

長時間作用型モノクローナル抗体の世界市場規模：供給源タイプ別、適応症別、エンドユーザー別、地域別の予測（2022年～2028年）

Global Long-acting Monoclonal Antibodies Market Size Study, By Source Type By Indication By End-User and regional forecasts 2022-2028
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=134.18円
長時間作用型モノクローナル抗体の世界市場規模：供給源タイプ別、適応症別、エンドユーザー別、地域別の予測（2022年～2028年）
出版日: 2022年04月22日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の長時間作用型モノクローナル抗体の市場規模は、慢性疾患の有病率の増加、座りがちな生活習慣の表面化、COVID-19の治療における使用、先進的な研究開発などによって促進されています。

一方で、モノクローナル抗体の高コストが予測期間中の同市場の拡大を妨げる可能性があります。

当レポートでは、世界の長時間作用型モノクローナル抗体市場を調査しており、市場の概要、市場分析、供給源タイプ・適応症・エンドユーザー・地域別の分析、および競合情勢など、包括的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の長時間作用型モノクローナル抗体市場の定義と範囲

第3章 世界の長時間作用型モノクローナル抗体市場力学

  • 長時間作用型モノクローナル抗体市場への影響分析（2020年～2028年）

第4章 世界の長時間作用型モノクローナル抗体市場：業界分析

  • ポーターのファイブフォースモデル
  • PEST分析
  • 投資採用モデル
  • アナリストの推奨事項と結論
  • 主要投資機会
  • 主要成功戦略

第5章 リスク評価：COVID-19の影響

    • 業界に対するCOVID-19の全体的な影響の評価
    • COVID-19前とCOVID-19後の市場シナリオ

第6章 世界の長時間作用型モノクローナル抗体市場：供給源タイプ別

  • 市場スナップショット
  • 供給源タイプ別の世界の長時間作用型モノクローナル抗体市場の実績-潜在性分析
  • 供給源タイプ別の世界の長時間作用型モノクローナル抗体市場の推定と予測（2019年～2028年）
  • 長時間作用型モノクローナル抗体市場、サブセグメント分析
  • ネズミ
  • キメラ
  • ヒト化
  • ヒト

第7章 世界の長時間作用型モノクローナル抗体市場：適応症別

  • 市場スナップショット
  • 適応症別の世界の長時間作用型モノクローナル抗体市場の実績-潜在性分析
  • 適応症別の世界の長時間作用型モノクローナル抗体市場の推定と予測（2019年～2028年）
  • 長時間作用型モノクローナル抗体市場、サブセグメント分析
  • 癌
  • 自己免疫疾患
  • 炎症性疾患
  • 感染症
  • その他

第8章 世界の長時間作用型モノクローナル抗体市場：エンドユーザー別

  • 市場スナップショット
  • エンドユーザー別の世界の長時間作用型モノクローナル抗体市場の実績-潜在性分析
  • エンドユーザー別の世界の長時間作用型モノクローナル抗体市場の推定と予測（2019年～2028年）
  • 長時間作用型モノクローナル抗体市場、サブセグメント分析
  • 病院薬局
  • ドラッグストア
  • 小売薬局
  • Eコマース

第9章 世界の長時間作用型モノクローナル抗体市場：地域別

  • 地域市場のスナップショット
  • 北米
    • 米国
    • カナダ
  • 欧州スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカスナップショット
    • ブラジル
    • メキシコ
  • その他の地域

第10章 競合情報

  • 主要市場戦略
  • 企業プロファイル
  • ELI LILLY
  • Abbott Laboratories
  • Astrazeneca Plc.
  • Amgen Inc.
  • Bayer Ag
  • Johnson & Johnson
  • Pfizer
  • Glaxosmithkline Plc.
  • Merck＆Co。Inc.
  • Novartis

第11章 調査プロセス

12.1調査プロセス

  • データマイニング
  • 分析
  • 市場の見積もり
  • 検証
  • 出版

12.2調査属性

12.3調査の前提条件

図表

LIST OF TABLES

  • TABLE 1. Global Long Acting Monoclonal Antibodies Market, report scope
  • TABLE 2. Global Long Acting Monoclonal Antibodies Market estimates & forecasts by Region 2019-2028 (USD Billion)
  • TABLE 3. Global Long Acting Monoclonal Antibodies Market estimates & forecasts by Source Type 2019-2028 (USD Billion)
  • TABLE 4. Global Long Acting Monoclonal Antibodies Market estimates & forecasts by Indication 2019-2028 (USD Billion)
  • TABLE 5. Global Long Acting Monoclonal Antibodies Market estimates & forecasts by End-User 2019-2028 (USD Billion)
  • TABLE 6. Global Long Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 7. Global Long Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 8. Global Long Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 9. Global Long Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 10. Global Long Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 11. Global Long Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 12. Global Long Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 13. Global Long Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 14. Global Long Acting Monoclonal Antibodies Market by segment, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 15. Global Long Acting Monoclonal Antibodies Market by region, estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 16. U.S. Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 17. U.S. Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 18. U.S. Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 19. Canada Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 20. Canada Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 21. Canada Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 22. UK Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 23. UK Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 24. UK Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 25. Germany Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 26. Germany Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 27. Germany Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 28. RoE Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 29. RoE Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 30. RoE Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 31. China Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 32. China Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 33. China Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 34. India Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 35. India Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 36. India Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 37. Japan Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 38. Japan Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 39. Japan Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 40. RoAPAC Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 41. RoAPAC Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 42. RoAPAC Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 43. Brazil Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 44. Brazil Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 45. Brazil Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 46. Mexico Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 47. Mexico Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 48. Mexico Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 49. RoLA Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 50. RoLA Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 51. RoLA Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 52. Row Long Acting Monoclonal Antibodies Market estimates & forecasts, 2019-2028 (USD Billion)
  • TABLE 53. Row Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 54. Row Long Acting Monoclonal Antibodies Market estimates & forecasts by segment 2019-2028 (USD Billion)
  • TABLE 55. List of secondary sources, used in the study of Global Long Acting Monoclonal Antibodies Market
  • TABLE 56. List of primary sources, used in the study of Global Long Acting Monoclonal Antibodies Market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Long Acting Monoclonal Antibodies Market, research methodology
  • FIG 2. Global Long Acting Monoclonal Antibodies Market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Long Acting Monoclonal Antibodies Market, key trends 2021
  • FIG 5. Global Long Acting Monoclonal Antibodies Market, growth prospects 2022-2028
  • FIG 6. Global Long Acting Monoclonal Antibodies Market, porters 5 force model
  • FIG 7. Global Long Acting Monoclonal Antibodies Market, pest analysis
  • FIG 8. Global Long Acting Monoclonal Antibodies Market, value chain analysis
  • FIG 9. Global Long Acting Monoclonal Antibodies Market by segment, 2019 & 2028 (USD Billion)
  • FIG 10. Global Long Acting Monoclonal Antibodies Market by segment, 2019 & 2028 (USD Billion)
  • FIG 11. Global Long Acting Monoclonal Antibodies Market by segment, 2019 & 2028 (USD Billion)
  • FIG 12. Global Long Acting Monoclonal Antibodies Market by segment, 2019 & 2028 (USD Billion)
  • FIG 13. Global Long Acting Monoclonal Antibodies Market by segment, 2019 & 2028 (USD Billion)
  • FIG 14. Global Long Acting Monoclonal Antibodies Market, regional snapshot 2019 & 2028
  • FIG 15. North America Long Acting Monoclonal Antibodies Market 2019 & 2028 (USD Billion)
  • FIG 16. Europe Long Acting Monoclonal Antibodies Market 2019 & 2028 (USD Billion)
  • FIG 17. Asia Pacific Long Acting Monoclonal Antibodies Market 2019 & 2028 (USD Billion)
  • FIG 18. Latin America Long Acting Monoclonal Antibodies Market 2019 & 2028 (USD Billion)
  • FIG 19. Global Long Acting Monoclonal Antibodies Market, company market share analysis (2021)
目次

Global Long-acting Monoclonal Antibodies Market is valued approximately USD xx Billion in 2021 and is anticipated to grow with a healthy growth rate of more than xx % over the forecast period 2022-2028. Long-acting Monoclonal antibodies (mAbs or moAbs) are antibodies created by cloning a single white blood cell. Every subsequent antibody generated in this manner may be traced back to a single parent cell. Monoclonal antibodies can only attach to the same epitope and have monovalent affinity (the part of an antigen that is recognised by the antibody). Growing prevalence of chronic diseases, surfacing sedentary lifestyle and use of MABs in the treatment of COVID-19 has driven the long-acting monoclonal antibodies market. For Instance: Eli Lilly discovers etesevimab, a monoclonal antibody that targets the receptor binding region of the SARS-CoV-2 surface spike protein. Also, on-going advanced research and development is most likely to boost the overall growth of the Global Long-acting Monoclonal Antibodies Market. However, high cost of mAbs can obstruct the market's expansion over the projection period of 2022-2028.

The key regions considered for the Global Long-acting Monoclonal Antibodies Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. US is the leading region across the world. Presence of major key players and leading industries in this region is driving the market growth in the North America. Whereas, Europe is also anticipated to exhibit highest growth rate over the forecast period 2022-2028. The market is expected to grow during the projected period, due to expanding R&D.

Major market player included in this report are:

Eli Lilly

Abbott Laboratories

AstraZeneca plc

Amgen Inc.

Bayer AG

Johnson & Johnson

Pfizer

GlaxoSmithKline Plc.

Merck & Co. Inc.

Novartis

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the Application within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Source Type:

Murine

Chimeric

Humanized

Human

By Indication:

Cancer

Autoimmune Disease

Inflammatory Disease

Infectious Disease

Others

By End-User:

Hospital Pharmacies

Drug Store

Retail Pharmacies

E-commerce

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Long-acting Monoclonal Anibodies Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
    • 1.2.1. Long Acting Monoclonal Antibodies Market, by Region, 2020-2028 (USD Billion)
    • 1.2.2. Long Acting Monoclonal Antibodies Market, by Source Type, 2020-2028 (USD Billion)
    • 1.2.3. Long Acting Monoclonal Antibodies Market, by Indication, 2020-2028 (USD Billion)
    • 1.2.4. Long Acting Monoclonal Antibodies Market, by End-user, 2020-2028 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Long Acting Monoclonal Antibodies Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Long Acting Monoclonal Antibodies Market Dynamics

  • 3.1. Long Acting Monoclonal Antibodies Market Impact Analysis (2020-2028)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increase prevalence of chronic diseases
      • 3.1.1.2. Surfacing sedentary lifestyle
      • 3.1.1.3. Emerging use of MABs in the treatment of Covid-19
    • 3.1.2. Market Challenges
      • 3.1.2.1. High cost
    • 3.1.3. Market Opportunities
      • 3.1.3.1. On-going advance research and development

Chapter 4. Global Long Acting Monoclonal Antibodies Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2019-2028)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economic
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion
  • 4.5. Top investment opportunity
  • 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

    • 5.1.1. Assessment of the overall impact of COVID-19 on the industry
    • 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Long Acting Monoclonal Antibodies Market, by Source Type

  • 6.1. Market Snapshot
  • 6.2. Global Long Acting Monoclonal Antibodies Market by Source Type, Performance - Potential Analysis
  • 6.3. Global Long Acting Monoclonal Antibodies Market Estimates & Forecasts by Source Type 2019-2028 (USD Billion)
  • 6.4. Long Acting Monoclonal Antibodies Market, Sub Segment Analysis
  • 6.4.1 Murine
  • 6.4.2 Chimeric
  • 6.4.3 Humanized
  • 6.4.4 Human

Chapter 7. Global Long Acting Monoclonal Antibodies Market, by Indication

  • 7.1. Market Snapshot
  • 7.2. Global Long Acting Monoclonal Antibodies Market by Indication, Performance - Potential Analysis
  • 7.3. Global Long Acting Monoclonal Antibodies Market Estimates & Forecasts by Indication 2019-2028 (USD Billion)
  • 7.4. Long Acting Monoclonal Antibodies Market, Sub Segment Analysis
  • 7.4.1 Cancer
  • 7.4.2 Autoimmune Disease
  • 7.4.3 Inflammatory Disease
  • 7.4.4 Infectious Disease
  • 7.4.5 Others

Chapter 8. Global Long Acting Monoclonal Antibodies Market, by End User

  • 8.1. Market Snapshot
  • 8.2. Global Long Acting Monoclonal Antibodies Market by End User, Performance - Potential Analysis
  • 8.3. Global Long Acting Monoclonal Antibodies Market Estimates & Forecasts by End Users 2019-2028 (USD Billion)
  • 8.4. Long Acting Monoclonal Antibodies Market, Sub Segment Analysis
  • 8.4.1 Hospital Pharmacies
  • 8.4.2 Drug Store
  • 8.4.3 Retail Pharmacies
  • 8.4.4 E-commerce

Chapter 9. Global Long Acting Monoclonal Antibodies Market, Regional Analysis

  • 9.1. Long Acting Monoclonal Antibodies Market, Regional Market Snapshot
  • 9.2. North America Long Acting Monoclonal Antibodies Market
    • 9.2.1. U.S. Long Acting Monoclonal Antibodies Market
      • 9.2.1.1. Source Type breakdown estimates & forecasts, 2019-2028
      • 9.2.1.2. Indication breakdown estimates & forecasts, 2019-2028
      • 9.2.1.3. End-User breakdown estimates & forecasts, 2019-2028
    • 9.2.2. Canada Long Acting Monoclonal Antibodies Market
  • 9.3. Europe Long Acting Monoclonal Antibodies Market Snapshot
    • 9.3.1. U.K. Long Acting Monoclonal Antibodies Market
    • 9.3.2. Germany Long Acting Monoclonal Antibodies Market
    • 9.3.3. France Long Acting Monoclonal Antibodies Market
    • 9.3.4. Spain Long Acting Monoclonal Antibodies Market
    • 9.3.5. Italy Long Acting Monoclonal Antibodies Market
    • 9.3.6. Rest of Europe Long Acting Monoclonal Antibodies Market
  • 9.4. Asia-Pacific Long Acting Monoclonal Antibodies Market Snapshot
    • 9.4.1. China Long Acting Monoclonal Antibodies Market
    • 9.4.2. India Long Acting Monoclonal Antibodies Market
    • 9.4.3. Japan Long Acting Monoclonal Antibodies Market
    • 9.4.4. Australia Long Acting Monoclonal Antibodies Market
    • 9.4.5. South Korea Long Acting Monoclonal Antibodies Market
    • 9.4.6. Rest of Asia Pacific Long Acting Monoclonal Antibodies Market
  • 9.5. Latin America Long Acting Monoclonal Antibodies Market Snapshot
    • 9.5.1. Brazil Long Acting Monoclonal Antibodies Market
    • 9.5.2. Mexico Long Acting Monoclonal Antibodies Market
  • 9.6. Rest of The World Long Acting Monoclonal Antibodies Market

Chapter 10. Competitive Intelligence

  • 10.1. Top Market Strategies
  • 10.2. Company Profiles
  • 10.2.1 ELI LILLY
    • 10.2.1.1 Key information
    • 10.2.1.2 Overview
    • 10.2.1.3 Financial (subject to data availability)
    • 10.2.1.4 Product summary
    • 10.2.1.5 Recent developments
  • 10.2.2 Abbott Laboratories
  • 10.2.3 Astrazeneca Plc.
  • 10.2.4 Amgen Inc.
  • 10.2.5 Bayer Ag
  • 10.2.6 Johnson & Johnson
  • 10.2.7 Pfizer
  • 10.2.8 Glaxosmithkline Plc.
  • 10.2.9 Merck & Co. Inc.
  • 10.2.10 Novartis

Chapter 11. Research Process

12.1 Research Process

  • 12.1.1 Data Mining
  • 12.1.2 Analysis
  • 12.1.3 Market Estimation
  • 12.1.4 Validation
  • 12.1.5 Publishing

12.2 Research Attributes

12.3 Research Assumption